Vir Combination 43742-2123
Generic: Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 Dna, Herpes Simplex Virus 2 Dna, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6a, Human Herpesvirus 6b, Influenzinum (2022-2023)
Product NDC
43742-2123- Manufacturer
- Deseret Biologicals, Inc.
- Dosage Form
- Liquid
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- January 25, 2024
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hepatitis B Virus | 33 [hp_X]/mL |
| Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen | 12 [hp_C]/mL |
| Human Herpesvirus 1 | 12 [hp_X]/mL |
| Human Herpesvirus 2 | 12 [hp_X]/mL |
| Human Herpesvirus 4 | 16 [hp_C]/mL |
| Human Herpesvirus 5 | 18 [hp_X]/mL |
| Human Herpesvirus 6 | 15 [hp_X]/mL |
| Influenza A Virus A/darwin/9/2021 Ivr-228 (h3n2) Antigen (uv, Formaldehyde Inactivated) | 12 [hp_X]/mL |
| Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (uv, Formaldehyde Inactivated) | 12 [hp_X]/mL |
| Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (uv, Formaldehyde Inactivated) | 12 [hp_X]/mL |
| Influenza B Virus B/phuket/3073/2013 Antigen (uv, Formaldehyde Inactivated) | 12 [hp_X]/mL |
Drug Class
Actively Acquired Immunity [PE]Live Human Adenovirus Type 4 Vaccine [EPC]Vaccines
Packaging Options(1)
30 mL in 1 BOTTLE, DROPPER (43742-2123-1)
External Resources